Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2002, p. 2698-2702, Vol. 40, No. 7
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.7.2698-2702.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
| CASE REPORT |
Department of Bacteriology at the University of Goettingen, Goettingen,3 Medizinische Klinik-Klinikum Innenstadt of the Ludwig-Maximilians University Muenchen, Munich,1 Medizinische Poliklinik,5 Institute for Hygiene and Microbiology at the University of Wuerzburg, Wuerzburg,6 Federal Biological Research Center for Agriculture and Forestry, Institute for Biological Control, Darmstadt, Germany,4 Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands2
Received 23 January 2002/ Returned for modification 24 March 2002/ Accepted 26 April 2002
ABSTRACT
Beauveria spp. are ubiquitous fungal entomopathogens that are commercially distributed as biological insecticides worldwide. In this paper we describe the clinical manifestation, diagnosis, and therapy of the first documented human deep tissue infection with an entomopathogenic Beauveria species in a patient receiving immunosuppressive therapy and describe the morphological and molecular characterization of the mold.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»